第1天 -2025年4月23日，星期三（北京时间）
分类
形式
09:30 - 10:30
60
分钟
全体会议
全球生物技术视角：与中国的创新与合作
Dan Wang -
Head of Innovation, APAC,
Johnson & Johnson
Grace Han McMahon -
AVP, Business Development,
MSD
Harm-Jan Borgeld -
Head of Asia Partnering,
Roche
Irene Hong -
Founding Partner,
CEC Capital
Matthias Müllenbeck -
SVP, Head Global BD & Alliance Management,
Merck KGaA
Ms. Marija Tadin-Strapps -
VP, Head of Discovery Network,
Pfizer
Yuguo Zang -
GM of BioParma China,
Boehringer Ingelheim
11:00 - 12:00
60
分钟
全体会议
中国生物技术的远见者：推动科学与研发的领导力
Barbara Lückel -
Global Head Technology Partnering, VP,
Roche
Darren Ji -
Chairman and CEO,
Elpiscience Biopharmaceuticals
Gang Qin -
CEO, Founder & Chairman,
GeneQuantum Healthcare
Jenny Yang -
Senior Director, Global Search & Evaluation,
Novo Nordisk
Jimmy Zhang -
Executive Mentor,
QB3 Bakar Labs / SVP BD, Frontier Biotech
Mia Hu -
Investment Director,
Boehringer Ingelheim
13:30 - 14:30
60
分钟
全体会议
2025年中国生命科学领域的五大风险与机遇
Chuan Sun -
Managing Partner,
Morrison Foerster
Derik Rao -
Partner,
Morrison Foerster
Iris Yuan -
Head of Legal and Compliance,
Duality Biologics
Linda Zhang -
Partner,
Innokylin Capital
Rongjing Zhao -
Partner,
Morrison Foerster
Sarah Wang -
Associate,
Morrison Foerster
16:05-17:05
60
分钟
全体会议
投资寒冬，春天即将来临？
Irene Hong -
Founding Partner,
CEC Capital
Ms Anta Gkelou -
Partner,
Sofinnova Partners
Patrick Schleck -
VP, Global TA Head Oncology,
Roche
Stella Xu -
Managing Director,
Quan Capital
Wei Wu -
Senior Director, Venture Investments, JJDC,
Johnson & Johnson
Yuwen Liu -
Founding Partner,
Bohe Capital
获取最新活动更新
注册以获取最新的活动更新和信息。
